Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Public Health ; 11: 1192542, 2023.
Article in English | MEDLINE | ID: mdl-37575128

ABSTRACT

Background and aims: The recent monkeypox (Mpox) outbreak confirmed by the World Health Organization (WHO) underscores the importance of evaluating the knowledge and attitude of medical students toward emerging diseases, given their potential roles as healthcare professionals and sources of public information during outbreaks. This study aimed to assess medical students' knowledge and attitude about Mpox and to identify factors affecting their level of knowledge and attitude in low-income and high-income countries. Methods: A cross-sectional study was conducted on 11,919 medical students from 27 countries. A newly-developed validated questionnaire was used to collect data on knowledge (14 items), attitude (12 items), and baseline criteria. The relationship between a range of factors with knowledge and attitude was studied using univariate and multivariate analyses. Results: 46% of the study participants were males; 10.7% were in their sixth year; 54.6% knew about smallpox; 84% received the coronavirus disease 2019 (COVID-19) vaccine; and 12.5% had training on Mpox. 55.3% had good knowledge of Mpox and 51.7% had a positive attitude towards it. Medical students in their third, fifth, or sixth year high- income countries who obtained information on Mpox from friends, research articles, social media and scientific websites were positive predictors for good knowledge. Conversely, being male or coming from high-income countries showed a negative relation with good knowledge about Mpox. Additionally, a positive attitude was directly influenced by residing in urban areas, being in the fifth year of medical education, having knowledge about smallpox and a history of receiving the coronavirus disease 2019 (COVID-19) vaccine. Receiving information about Mpox from social media or scientific websites and possessing good knowledge about Mpox were also predictors of a positive attitude. On the other hand, being male, employed, or receiving a training program about Mpox were inversely predicting positive attitude about Mpox. Conclusion: There were differences in knowledge and attitude towards Mpox between medical students in low and high-income countries, emphasizing the need for incorporating epidemiology of re-emerging diseases like Mpox into the medical curriculum to improve disease prevention and control.


Subject(s)
COVID-19 , Mpox (monkeypox) , Smallpox , Students, Medical , Humans , Male , Female , Cross-Sectional Studies , COVID-19/epidemiology , COVID-19 Vaccines
3.
Front Med (Lausanne) ; 8: 608959, 2021.
Article in English | MEDLINE | ID: mdl-33708777

ABSTRACT

In 2020, the World Health Organization has characterized COVID-19, a disease caused by infection with the SARS-CoV-2 virus, as a pandemic. Although a few vaccines and drugs have been approved to, respectively, prevent or treat the disease, several clinical trials are still ongoing to test new vaccines or drugs to mitigate the burden of the pandemic. Few studies have shown the role of host genetics in disease prognosis and drug response highlighting the importance of diverse participation in COVID-19 clinical trials. The goal of this study is to assess public attitudes in Egypt, Saudi Arabia, and Jordan toward participating in COVID-19 clinical trials and to identify the factors that may influence their attitude. An online questionnaire was developed and distributed among the target group through social media platforms. The number of responses was 1,576. Three quarters (74.9%) of participants heard about clinical trials before, 57.6% of them had a positive attitude toward participation in COVID-19 clinical trials. The conduct of clinical trials in accordance with the scientific, research, and ethical guidelines was a strong predictor of willingness to participate in clinical trials. Other positive factors also included protection of family from COVID-19 and contributing to the return to normal community life as well as receiving additional healthcare benefit was the fourth significant predictor. On the other hand, the thought that clinical trials can have a negative impact on the health of participants strongly predicted the unwillingness of individuals to participate in such trials. This was followed by having limited information about the novel coronavirus and COVID-19 and the lack of trust in physicians and hospitals. In general, Arab citizens are accepting the concept and have a positive attitude toward COVID-19 clinical trials. Increasing awareness of COVID-19 and clinical trials, enforcing the concept of altruism, and placing clear policies in conducting clinical trials are needed to increase participation in clinical trials among Arabs.

4.
Cardiovasc Drugs Ther ; 35(6): 1095-1110, 2021 12.
Article in English | MEDLINE | ID: mdl-32474680

ABSTRACT

PURPOSE: This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute myocardial infarction (MI) in rats involves inhibition of the Wnt1/ß-catenin signaling pathway. METHODS: Rats were divided into sham, sham + Exendin-4 (10 µg/day, i.p), MI, and MI + Exendin-4. MI was introduced to rats by permanent left anterior descending coronary artery (LAD) ligation. RESULTS: On day 7 post-infraction, MI rats showed LV dysfunction with higher serum levels of cardiac markers. Their remote myocardia showed increased mRNA and protein levels of collagen I/III with higher levels of reactive oxygen species (ROS) and inflammatory cytokines, as well as protein levels of Wnt1, phospho-Akt, transforming growth factor (TGF-ß1), Smad, phospho-Smad3, α-SMA, caspase-3, and Bax. They also showed higher protein levels of phospho-glycogen synthase kinase-3ß (p-GSK3ß), as well as total, phosphorylated, and nuclear ß-catenin with a concomitant decrease in the levels of cyclic adenosine monophosphate (cAMP), mRNA of manganese superoxide dismutase (MnSOD), and protein levels of Bcl-2, ß-arrestin-2, and protein phosphatase-2 (PP2A). Administration of Exendin-4 to MI rats reduced the infarct size and reversed the aforementioned signaling molecules without altering protein levels of TGF-1ß and Wnt1 or Akt activation. Interestingly, Exendin-4 increased mRNA levels of MnSOD, protein levels of ß-arrestin-2 and PP2A, and ß-catenin phosphorylation but reduced the phosphorylation of GSK3ß and Smad3, and total ß-catenin levels in the LV of control rats. CONCLUSION: Exendin-4 inhibits the remodeling in the remote myocardium of rats following acute MI by attenuating ß-catenin activation and activating ß-arrestin-2, PP2A, and GSK3ß. Graphical Abstract A graphical abstract that illustrates the mechanisms by which Exendin-4 inhibits cardiac remodeling in remote myocardium of left ventricle MI-induced rats. Mechanisms are assumed to occur in the cardiomyocytes and/or other resident cells such as fibroblast. Β-catenin activation and nuclear translocation are associated with increased synthesis of inflammatory cytokines and transforming growth factor ß-1 (TGF-ß1). GSK3ß is inhibited by phosphorylation at Ser9. Under normal conditions, ß-catenin is degraded in the cytoplasm by the active GSK3ß-dependent degradation complex (un-phosphorylated) which usually phosphorylates ß-catenin at Ser33/37/Thr41. After MI, TGF-ß1, and Wnt 1 levels are significantly increased, the overproduction of Wnt1 induces ß-catenin stabilization and nuclear translocation through increasing the phosphorylation of disheveled (DVL) protein which in turn phosphorylates and inhibits GSK3ß. TGF-ß1 stimulates the phosphorylation of Smad-3 and subsequent nuclear translocation to activate the transcription of collage 1/III and α-smooth muscle actin (α-SMA). Besides, TGF-ß1 stabilizes cytoplasmic ß-catenin levels indirectly by phosphorylation of Akt at Thr308-induced inhibition of GSK3ß by increasing phosphorylation of Ser9. Exendin-4, and possibly through G protein-coupled receptors (GPCRs), increases levels of cAMP and upregulates ß-arrestin-2 levels. Both can result in a positive inotropic effect. Besides, ß-arrestin-2 can stimulate PP2A to dephosphorylation Smad3 (inhibition) and GSK3ß (activation), thus reduces fibrosis and prevents the activation of ß-catenin and collagen deposition.


Subject(s)
Exenatide/pharmacology , Glycogen Synthase Kinase 3/drug effects , Myocardial Infarction/physiopathology , Protein Phosphatase 2/drug effects , beta Catenin/drug effects , beta-Arrestins/drug effects , Animals , Hemodynamics/drug effects , Male , Phosphorylation , Rats , Rats, Wistar , Wnt1 Protein/drug effects
5.
J Ayub Med Coll Abbottabad ; 24(3-4): 43-6, 2012.
Article in English | MEDLINE | ID: mdl-24669606

ABSTRACT

BACKGROUND: Worldwide Ministries of Health (MoH) are encouraged to publish an updated Over-the-Counter (OTC)-Directory that pharmacists should adhere to in dispensing non-prescription medications. The Saudi Ministry of Health has published the OTC-Directory in the year 2000, and since then, it was readily available to all practicing pharmacists at no cost. This study was aimed to investigate the knowledge of practicing pharmacists in Riyadh, Saudi Arabia, regarding permitted self-prescription medications (i.e., OTC-Directory), as well as pharmacists professional competence and adherence at dispensing OTC drugs without prescription. METHODS: The study was cross-sectional by design. A computer generated list of simple random sampling was used to select the pharmacies out of 1,500 working in Riyadh. The data was collected from 384 randomly selected community pharmacies by questionnaire using direct investigation method and the total respondents were 405. Associations between qualitative variables were observed using Pearson Chi-square and Fisher Exact test. RESULTS: Four hundred and five (405) pharmacists participated in the survey of which 100% were males and 362 (89.4%) were below the age of 40 years. Majority of them (361, 88.9%) were holding bachelors degree. Almost one-third of the respondents (123, 30.4%) were not aware of the existence of the Saudi OTC-Directory. The pharmacists' geographical location, nationality and attendance of CME activity had significant association with knowledge about the OTC-directory (p < 0.05). Two hundred and eighty-two (69.6%) of the pharmacists who had knowledge about Saudi OTC-directory did not comply with its guidelines. Pharmacists with higher degrees were more observant of the OTC-Directory as compared to those with diploma and Bachelor Degree (p = 0.014). CONCLUSIONS: There is significant non-compliance of OTC-directory by the community pharmacists while providing non-prescription drugs in Riyadh, Saudi Arabia.


Subject(s)
Guideline Adherence , Nonprescription Drugs , Pharmacists , Adult , Cross-Sectional Studies , Humans , Male , Saudi Arabia , Self Medication , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...